Auf ECHEMI
DE
2024-08-12
The news quickly garnered widespread attention as it heralded the arrival of a new player in a high-profile drug market competition.
2024-08-09
On August 9, 2024, the company announced that it had successfully won back global development and commercialization rights to HBM7008 from Cullinan Oncology.
2024-08-09
Iovance is building Amtagvi, an immune cell therapy product based on the company's unique autotumor-infiltrating lymphocyte (TIL) technology.
2024-08-09
When discussing the broad landscape of women's health, female menopause is undoubtedly a focus of attention.
2024-08-08
A revolutionary drug developed by Novartis Pharmaceuticals, designated for the treatment of immunoglobulin A kidney disease (IgAN). A rare but widespread kidney disease.
2024-08-08
Amax Pharmaceuticals finally ushered in a brilliant victory in the United States, its signature innovative delayed release Parkinson's disease treatment drug - Crexont, successfully obtained the authoritative approval of the United States FDA.
2024-08-08
The latest release shows that Humanwell Healthcare has delivered remarkable results in the first half of 2024, demonstrating excellent market performance.
2024-08-08
An amyotrophic lateral sclerosis (ALS) drug with annual sales of $400 million has been mockingly likened by industry analysts to "its efficacy is not as cool as mints".
2024-08-08
In 2022, Gilead announced that it would voluntarily withdraw Zydelig from the U.S. market for two lymphoma treatments, a full six years after it suspended the trial due to patient deaths.
2024-08-07
On July 29, Boehringer Ingelheim announced a major acquisition, with plans to buy Nerio Therapeutics for $1.3 billion.
2024-08-06
Recently, the Hong Kong stock market's innovative pharmaceutical giant - Genor Biological (06998.HK) and the United States biotechnology company TRC2004,Inc.
2024-08-06
China's pharmaceutical industry ushered in a major equity change, China Resources Sanjiuannounced that it will buy 28% of Tasly's shares at a high price of 6.212 billion yuan, which marks another major expansion of China Resources Pharmaceutical territory
2024-08-05
In the bright river of stars in the field of medicine, a new star is rising slowly, which has lit up the light of hope for countless patients with alopecia areata.
2024-08-02
The results will undoubtedly bring takeda pharmaceuticals of new drug research and development of the road for a certain amount of uncertainty.
2024-08-02
RSV vaccine was known as a shining star in the pharmaceutical industry, and its market potential was placed high hopes by investors and experts, like an infinite blue ocean.
2024-08-02
Abbvie company on August 1, 2024 announced a major industry trends, has won regulatory approval across the globe, success with $8.7 billion purchased biotechnology company focused on neuroscience Cerevel Therapeutics.
2024-08-02
Vertex Pharmaceuticals, known for its outstanding contributions to the treatment of rare diseases, has recently made significant breakthroughs in new medical fields.
2024-08-02
The development of semaglutide, a miracle drug, is a saga of challenges and breakthroughs.
2024-08-01
Recently, Pfizer, the world-famous pharmaceutical giant, announced a remarkable decision to officially terminate the development process of its gene therapy Fordadistrogene movaparvovec (PF-06939926) for Duchenne muscular dystrophy (DMD).
2024-08-01
In July 2024, Lotte biological agents in Incheon, South Korea pine island biological park to start the construction of the new plant, marks its layout in the field of biological medicine took a substantive step.